Epidermoid Carcinoma of the Anal Canal

ABSTRACT

Anal cancers are rare tumors with only an expected 4000 new diagnoses in 2005. The majority of these are epidermoid or squamous cell cancers. Despite the rarity of this disease, great advances have been made in its understanding and treatment. The human papillomavirus (HPV), immunosuppression for solid organ transplantation, the human immunodeficiency virus (HIV), and sexual practices are changing the demographics of the disease from elderly women to young men who have sex with men and young women infected with HPV and HIV. The treatment of these malignancies was radically changed with Dr. Nigro's description in 1974 of the use of a nonoperative treatment strategy. Today, radiochemotherapy represents first-line therapy and the role of surgery has been largely relegated to that of salvage therapy for treatment failures of nonoperative management.

Epidermoid cancer - anal canal - squamous cancer

REFERENCES

• 1 Jemal A, Murray T, Ward E et al.. Cancer statistics 2005.  CA Cancer J Clin. 2005;  55 10-30
• 2 Ryan D P, Compton C C, Mayer R J. Carcinoma of the anal canal.  N Engl J Med. 2000;  342 792-800
• 3 Nguyen W, Beck D E. Epidermoid carcinoma of the anal canal.  Clin Colon Rectal Surg. 2002;  15 263-270
• 4 Greene FL, Page DL, Fleming ID, et al AJCC Cancer Staging Manual. American Joint Committee on Cancer. 6th ed. New York; Springer-Verlag 2002
• 5 Morson B C, Sobin L H. Histologic Typing of Intestinal Tumors. Geneva; World Health Organization 1976: 67-69
• 6 Jass J R, Sobin L H. Histologic Typing of Intestinal Tumors: World Health Organization. 2nd ed. New York; Springer-Verlag 1989: 41-47
• 7 Tung W, Nivatvongs S. Perianal and anal canal neoplasms. In: Gordon PH, Nivatvons S Principles and Practice of Surgery for the Colon, Rectum, and Anus. 2nd ed. Saint Louis; Quality Medical Publishing 1999: 401-417
• 8 Grinvalsky H T, Helwig E G. Carcinoma of the anorectal junction. I. Histologic considerations.  Cancer. 1956;  9 480-488
• 9 Daling J R, Weiss N S, Hislop T G et al.. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer.  N Engl J Med. 1987;  317 973-977
• 10 Daling J R, Weiss N S, Klopfenstein L L, Cochran L E, Chow W H, Daifuku R. Correlates of homosexual behavior and the incidence of anal cancer.  JAMA. 1982;  247 1988-1990
• 11 Peters R K, Mack T M. Patterns of anal carcinoma by gender and marital status in Los Angeles County.  Br J Cancer. 1983;  48 629-636
• 12 Broker T R, Botchan M. Papillomaviruses: retrospectives and prospectives.  Cancer Cells. 1986;  4 17-36
• 13 Palefsky J M, Holly E A, Gonzales J, Berline J, Ahn D K, Greenspan J S. Detection of human papillomavirus DNA in anal intraepithelial neoplasia and anal cancer.  Cancer Res. 1991;  51 1014-1019
• 14 Shroyer K R, Kim J G, Manos M M, Greer C E, Pearlman N W, Franklin W A. Papillomavirus found in anorectal squamous carcinoma, not in colon adenocarcinoma.  Arch Surg. 1992;  127 741-744
• 15 Frisch M, Glimelius B, van den Brule A J et al.. Sexually transmitted infection as a cause of anal cancer.  N Engl J Med. 1997;  337 1350-1358
• 16 Howley P M. On human papillomaviruses.  N Engl J Med. 1986;  315 1089-1090
• 17 Duggan M A, Boras V F, Inoue M, McGregor S E, Robertson D I. Human papillomavirus DNA determination of anal condylomata, dysplasias, and squamous carcinomas with in situ hybridization.  Am J Clin Pathol. 1989;  92 16-21
• 18 Williams G R, Lu O L, Love S B, Talbot I C, Northover J M. Properties of HPV-positive and HPV-negative anal carcinomas.  J Pathol. 1996;  180 378-382
• 19 Holly E A, Whittemore A S, Aston D A, Ahn D K, Nickoloff B J, Kristiansen J J. Anal cancer incidence: genital warts, anal fissure or fistula, hemorrhoids, and smoking.  J Natl Cancer Inst. 1989;  81 1726-1731
• 20 Frisch M, Melbye M, Moller H. Trends in incidence of anal cancer in Denmark.  BMJ. 1993;  306 419-422
• 21 Melbye M, Rabkin C, Frisch M, Biggar R J. Changing patterns of anal cancer incidence in the United States, 1940-1989.  Am J Epidemiol. 1994;  139 772-780
• 22 Kiviat N, Rompalo A, Bowden R et al.. Anal human papillomavirus infection among human immunodeficiency virus-seropositive and -seronegative men.  J Infect Dis. 1990;  162 358-361
• 23 Williams A B, Darragh T M, Vranizan K, Ochia C, Moss A R, Palefsky J M. Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women.  Obstet Gynecol. 1994;  83 205-211
• 24 Palefsky J M, Holly E A, Hogeboom C J et al.. Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men.  J Acquir Immune Defic Syndr Hum Retrovirol. 1998;  17 314-319
• 25 Melbye M, Cote T R, Kessler L, Gail M, Biggar R J. High incidence of anal cancer among AIDS patients.  Lancet. 1994;  343 636-639
• 26 Selik R M, Rabkin C S. Cancer death rates associated with human immunodeficiency virus infection in the United States.  J Natl Cancer Inst. 1998;  90 1300-1302
• 27 Rabkin C S, Yellin F. Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1.  J Natl Cancer Inst. 1994;  86 1711-1716
• 28 Goedert J J, Cote T R, Virgo P et al.. Spectrum of AIDS-associated malignant disorders.  Lancet. 1998;  351 1833-1839
• 29 Frisch M, Biggar R J, Engels E A, Goedert J J. Association of cancer with AIDS-related immunosuppression in adults.  JAMA. 2001;  285 1736-1745
• 30 Bower M, Powles T, Newsom-Davis T et al.. HIV-associated anal cancer. Has highly active antiretroviral therapy reduced the incidence or improved the outcome?.  J Acquir Immune Defic Syndr. 2004;  37 1563-1565
• 31 Frisch M, Biggar R J, Goedert J J. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome.  J Natl Cancer Inst. 2000;  92 1500-1510
• 32 Penn I. Cancers of the anogenital region in renal transplant recipients: analysis of 65 cases.  Cancer. 1986;  58 611-616
• 33 Arends M J, Benton E C, McLaren K M, Stark L A, Hunter J A, Bird C C. Renal allograft recipients with high susceptibility to cutaneous malignancy have an increased prevalence of human papillomavirus DNA in skin tumours and a greater risk of anogenital malignancy.  Br J Cancer. 1997;  75 722-728
• 34 Holmes F, Borek D, Owen-Kummer M et al.. Anal cancer in women.  Gastroenterology. 1988;  95 107-111
• 35 Daling J R, Sherman K J, Hislop T G et al.. Cigarette smoking and the risk of anogenital cancer.  Am J Epidemiol. 1992;  135 180-189
• 36 Buckwalter J A, Jurayi M N. Relationship of chronic anorectal disease to carcinoma.  Arch Surg. 1957;  75 352-361
• 37 Kline R J, Spencer R J, Harrison Jr E G. Carcinoma associated with fistula-in-ano.  Arch Surg. 1964;  89 989-994
• 38 Frisch M, Olsen J H, Bautz A, Melbye M. Benign anal lesions and the risk of anal cancer.  N Engl J Med. 1994;  331 300-302
• 39 Boman B M, Moertel C G, O'Connell M J et al.. Carcinoma of the anal canal: a clinical and pathologic study of 188 cases.  Cancer. 1984;  54 114-125
• 40 Pintor M P, Northover J M, Nicholls R J. Squamous cell carcinoma of the anus at one hospital from 1948 to 1984.  Br J Surg. 1989;  76 806-810
• 41 Schlienger M, Krzisch C, Pene F et al.. Epidermoid carcinoma of the anal canal treatment results and prognostic variables in a series of 242 cases.  Int J Radiat Oncol Biol Phys. 1989;  17 1141-1151
• 42 Touboul E, Schlienger M, Buffat L et al.. Epidermoid carcinoma of the anal canal: results of curative-intent radiation therapy in a series of 270 patients.  Cancer. 1994;  73 1569-1579
• 43 Nigro N D, Vaitkevicius V K, Considine Jr B. Combined therapy for cancer of the anal canal: a preliminary report.  Dis Colon Rectum. 1974;  17 354-356
• 44 Beahrs O H, Wilson S M. Carcinoma of the anus.  Ann Surg. 1976;  184 422-428
• 45 Pocard M, Tiret E, Nugent K, Dehni N, Pare R. Results of salvage abdominoperineal resection for anal cancer after radiotherapy.  Dis Colon Rectum. 1998;  41 1488-1493
• 46 Klas J V, Rothenberger D A, Wong W D, Madoff R D. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes.  Cancer. 1999;  85 1686-1693
• 47 Allal A S, Laurencet F M, Reymond M A, Kurtz J M, Marti M C. Effectiveness of surgical salvage therapy for patients with locally uncontrolled anal carcinoma after sphincter-conserving treatment.  Cancer. 1999;  86 405-409
• 48 Nilsson P J, Svensson C, Goldman S, Glimelius B. Salvage abdominoperineal resection in anal epidermoid cancer.  Br J Surg. 2002;  89 1425-1429
• 49 Renehan A G, Saunders M P, Schofield P F, O'Dwyer S T. Patterns of local disease failure and outcome after salvage surgery in patients with anal cancer.  Br J Surg. 2005;  92 605-614
• 50 Touboul E, Schlienger M, Buffat L et al.. Epidermoid carcinoma of the anal canal: results of curative-intent radiation therapy in a series of 270 patients.  Cancer. 1994;  73 1569-1579
• 51 Hughes L L, Rich T A, Delclos L, Ajani J A, Martin R G. Radiotherapy for anal cancer: experience from 1979-1987.  Int J Radiat Oncol Biol Phys. 1989;  17 1153-1160
• 52 Leichman L, Nigro N, Vaitkevicius V K et al.. Cancer of the anal canal: model for preoperative adjuvant combined modality therapy.  Am J Med. 1985;  78 211-215
• 53 UKCCCR Anal Cancer Trial Working Party . Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin.  Lancet. 1996;  348 1049-1054
• 54 Bartelink H, Roelofsen F, Eschwege F et al.. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.  J Clin Oncol. 1997;  15 2040-2049
• 55 Flam M, John M, Pajak T F et al.. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.  J Clin Oncol. 1996;  14 2527-2539
• 56 Rotman M, Lange C S. Anal cancer: radiation and concomitant continuous infusion chemotherapy.  Int J Radiat Oncol Biol Phys. 1991;  21 1385-1387
• 57 Bottomley D M, Aqel N, Selvaratnam G, Phillips R H. Epidermoid anal cancer in HIV infected patients.  Clin Oncol (R Coll Radiol). 1996;  8 319-322
• 58 Cleator S, Fife K, Nelson M et al.. Treatment of HIV-associated invasive anal cancer with combined chemoradiation.  Eur J Cancer. 2000;  36 754-758
• 59 Hocht S, Wiegel T, Kroesen A J et al.. Low acute toxicity of radiotherapy and radiochemotherapy in patients with cancer of the anal canal and HIV-infection.  Acta Oncol. 1997;  36 799-802
• 60 Kim J, Sarani B, Orkin B et al.. HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients.  Dis Colon Rectum. 2001;  44 1496-1502
• 61 Hoffman R, Welton M L, Klencke B, Weinberg V, Krieg R. The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer.  Int J Radiat Oncol Biol Phys. 1999;  44 127-131
• 62 Peddada A V, Smith D E, Rao A R, Frost D B, Kagan A R. Chemotherapy and low-dose radiotherapy in the treatment of HIV-infected patients with carcinoma of the anal canal.  Int J Radiat Oncol Biol Phys. 1997;  37 1101-1105
• 63 Akbari R P, Paty P B, Guillem J G et al.. Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapy.  Dis Colon Rectum. 2004;  47 1136-1144